There are 3 biases that we see in studies:
โถ๏ธ Some asymptomatics are actually pre-symptomatic.
โถ๏ธ Some studies focus on a small or categorized sample
2) ... (population with cancer, renal dialysis, neonatal, etc.)
โถ๏ธ The severity of the symptoms is sometimes difficult to assess (slight fever or slight cough is a symptom of COVID).
We can see these differences ranging from 22 to 85% depending on the studies.
3) The previous table comes from a mega-analysis by Eric Topol, which gave a median rate of 41% of asymptomatic people. ncbi.nlm.nih.gov/pmc/articles/Pโฆ
4) We have taken all the studies, limiting ourselves to the one published in 2024, like this one for Hong Kong. Here the asymptomatic rate is 75% wwwnc.cdc.gov/eid/article/30โฆ
5) The most interesting in our opinion are seroprevalence studies, because they make it possible to measure the number of infected cases while avoiding the pre-symptomatic and asymptomatic debate. hindawi.com/journals/cjidmโฆ
8) More asthmatics with COVID-19 than with INFLUENZA?
We only found 3 studies for influenza, sometimes quite old but which dont seem really significant, with rates between 30 and 50% of asymptomatic.
9) When more than one in two people are asymptomatic and therefore difficult to detect, and with a risk of long COVID as many studies show it, we have a circulation of the virus which is uncontrollable and we continue to affirm that it is a real tragedy in terms of public health.
10) Sorry for the typo mistake. On the post 8 it is "asymptomatics" and not "asthmatics" ๐คทโโ๏ธ
โข โข โข
Missing some Tweet in this thread? You can try to
force a refresh
NIPAH VIRUS
Jumping to conclusions during outbreaks only fuels panic and misunderstanding; NOT EVERY VIRUS OUTBREAK is a PANDEMIC.
We raised the alarm about Nipah in 2023, but itโs essential not to confuse an epidemic related to this virus, ...
2) ...like the one in India, with a pandemic risk or a situation like COVID-19.
Nipah virus is transmitted primarily from animals, especially bats, to humans. It spreads through direct contact with infected animals, their secretions, or contaminated foods.
3) Human-to-human transmission occurs only through close contact, such as touching or caring for an infected person, as well as sharing fluids like saliva or blood.
We cannot equate a virus transmitted through fluids with a respiratory virus like SARS-CoV-2.
"70% to 90% of our CELLS are completely RENEWED in less than 5 YEARS!
So If weโre mostly "New", why are so many still struggling with SARS-CoV-2?
We will tackle this question, which is more complex than it seems, in several posts.
2) First, let's say a few words about cell renewal.
70% to 90% of our cells are renewed over time. This turnover occurs in various cell types, including skin, blood, and immune cells, allowing the body to replace damaged or aged cells. sciencefocus.com/the-human-bodyโฆ
3) For instance, red blood cells have a lifespan of about 120 days, while skin cells regenerate every few weeks.
Even with significant cell renewal, aging persists due to changes in our DNA. sciencefocus.com/the-human-bodyโฆ
2) Co-infection occurs when a person is infected by more than one virus at the same time. This can lead to interesting and sometimes complex interactions between the viruses
3) In one study about SARS-CoV-2, researchers found that when different versions of this virus infect the same person, they can mix their genetic material through a process called recombination. This means that the new version of the virus can have traits from both parent viruses
For more than three years, we have been emphasizing that the envelope protein is an essential component and that we cannot limit our focus to just the spike protein. We are now uncovering its role in long COVID.
3) The Envelope (E) protein of SARS-CoV-2 plays a crucial role for several reasons:
โถ๏ธ Virus Assembly and Release: The E protein is essential for the virus's assembly and budding from infected cells, contributing to its stability and infectivity.
"N''oubliez jamais" (Never forget - Joe Cocker)๐งต
In 2022, COVID-19 was the second leading cause of death globally, with the repercussions of the virus far from over. The lasting impact of the pandemic continues to affect lives around the world.
Recent research may have identified a key factor contributing to long COVID: microscopic clots intertwined with immune system debris in the blood. These unusual structures were found to be nearly 20 times more prevalent ...
2) ...in long COVID patients compared to healthy individuals. The clots, associated with neutrophil extracellular traps (NETs), suggest a potential biological marker for persistent symptoms.
3) These microclots could impede blood flow in small vessels, leading to issues like brain fog, fatigue, and shortness of breath.